Search results
NeuroSense Announces First Quarter 2024 Business Update
WRBL Columbus· 1 day agoNeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update. "We were honored to ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoDr. Brijesh Mehta is one of approximately 20 physicians in the U.S. trained to use Medtronic's Pipeline Vantage device for treatment of brain aneurysms, with his leadership role within Memorial ...